Personal profile
Main research areas
Intestinal failure; Short bowel syndrome; Malabsorption; Macro- and Micro-nutrient absorption; Home Parenteral Nutrition; Parenteral Support; IF Epidemiology; HPN complications; Catheter Related Bloodstream Infections; Central Venous Thrombosis; Intestinal Failure Associated Liver Disease; Medical Treatment: Anti-diarrhoeals, Anti-secretory agents; Intestinal Growth Factors; Glucagon-like peptide 1 and 2. Peptide YY, FGF19; Gut-liver axis;Metabolic balance studies; Inflammatory bowel disease
Expertises
Intestinal failure; Short bowel syndrome; Malabsorption; Macro- and Micro-nutrient absorption; Home Parenteral Nutrition; Parenteral Support; IF Epidemiology; HPN complications; Catheter Related Bloodstream Infections; Central Venous Thrombosis; Intestinal Failure Associated Liver Disease; Medical Treatment: Anti-diarrhoeals, Anti-secretory agents; Intestinal Growth Factors; Glucagon-like peptide 1 and 2. Peptide YY, FGF19; Gut-liver axis; Metabolic balance studies; Inflammatory bowel disease
Current research
Intestinal failure; Short bowel syndrome; Malabsorption; Macro- and Micro-nutrient absorption; Home Parenteral Nutrition; Parenteral Support; IF Epidemiology; HPN complications; Catheter Related Bloodstream Infections; Central Venous Thrombosis; Intestinal Failure Associated Liver Disease; Medical Treatment: Anti-diarrhoeals, Anti-secretory agents; Intestinal Growth Factors; Glucagon-like peptide 1 and 2. Peptide YY, FGF19; Gut-liver axis;Metabolic balance studies; Inflammatory bowel disease
Potential conflicts of interest
Grants/ research support from the Novo Nordic Foundation; honoraria or consultation fees from NPS Pharma, Shire, Ferring, Baxter, Fresenius Kabi, Zealand Pharma, Naia Pharma and the Aguettant Institute.
External positions
University of Copenhagen
2005 → …
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
GLP-2 analogues in short bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
Castro, P. B., Brandão, H. S., Martins de Araujo, G., Silva, G. P., Carvalho, L. G., Jeppesen, P. B. & dos Santos Pereira, S. I., Feb 2026, In: Clinical Nutrition ESPEN . 71, 102881.Research output: Contribution to journal › Review › peer-review
-
Investigation of the stool microbiome of Short Bowel Syndrome patients before and after a 24-week treatment with the Glucagon-like Peptide 2 analog glepaglutide
Pinar, I., Nielsen, T. S. S., Brach, T., Moll, J. M., Nielsen, B. H., Hvistendahl, M. K., Berner-Hansen, M. & Jeppesen, P. B., 25 Feb 2026, (E-pub ahead of print) In: Clinical Nutrition ESPEN . p. 102989Research output: Contribution to journal › Journal article › Research › peer-review
-
Proglucagon-derived Peptides: Human Physiology and Therapeutic Potential
Gasbjerg, L. S., Nielsen, C. K., Suppli, M. P., Grøendahl, M. F. G., Holst, J. J., Knop, F. K., Jeppesen, P. B. & Lund, A. B., 1 Jan 2026, In: Physiological Reviews. 106, 1, p. 529-586 58 p.Research output: Contribution to journal › Review › peer-review
2 Citations (Scopus) -
Qualitative Research for the Development of Three New Quality of Life and Treatment Impact Questionnaires for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Vanuytsel, T., Joly, F., Iyer, K., Bolognani, F., Mitchell, G., Berger, S., Lamoureux, R., Litcher-Kelly, L., Lowe, C., Medrano, P., Boules, M. & Jeppesen, P., 16 Jan 2026, (E-pub ahead of print) In: Digestive Diseases and Sciences.Research output: Contribution to journal › Journal article › Research › peer-review
-
Assessment of liver stiffness and steatosis in patients with intestinal failure: a cross-sectional study
Muhic, E., Naimi, R. M., Brandt, C. F., Andersen, T. L., Johannesen, H. H. & Jeppesen, P. B., 11 Dec 2025, In: Frontiers in nutrition. 12, 9 p., 1718310.Research output: Contribution to journal › Journal article › Research › peer-review